Publication:
Quality of life measurement in urticaria: position statement of the European Academy of Dermatology and Venereology task forces on quality of life and patient-oriented outcomes and urticaria and angioedema

Placeholder

Organizational Units

Program

KU-Authors

KU Authors

Co-Authors

Chernyshov, P. V.
Finlay, A. Y.
Tomas-Aragones, L.
Zuberbier, T.
Manolache, L.
Pustisek, N.
Svensson, A.
Marron, S. E.
Sampogna, F.
Bewley, A.

Advisor

Publication Date

2024

Language

en

Type

Journal article

Journal Title

Journal ISSN

Volume Title

Abstract

The European Academy of Dermatology and Venereology (EADV) Task Forces on quality of life (QoL) and patient-oriented outcomes and on urticaria and angioedema recommendations for the assessment of Health-related (HR) QoL in all patients with urticaria in research and practice are as follows: to use the DLQI for adults and the CDLQI for children as dermatology-specific and the CU-Q2oL as a disease-specific HRQoL instruments in urticaria; to use generic instruments to provide comparison of data on urticaria with non-dermatologic diseases, or to compare with healthy volunteers or the general population; to select validated HRQoL instruments with appropriate age limits; to present exact numeric data for HRQoL results; correct title of any HRQoL instrument should be used, along with its correct abbreviation and the reference to its original publication, where possible. The EADV TFs discourage the use of non-validated HRQoL instruments and modified HRQoL instruments that have not undergone standard validation.

Description

Source:

Journal of the European Academy of Dermatology and Venereology

Publisher:

Wiley

Keywords:

Subject

Dermatology

Citation

Endorsement

Review

Supplemented By

Referenced By

Copy Rights Note

0

Views

0

Downloads

View PlumX Details